Natixis Advisors L.P. increased its holdings in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 25.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,468 shares of the company’s stock after buying an additional 14,967 shares during the quarter. Natixis Advisors L.P.’s holdings in Option Care Health were worth $2,334,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in OPCH. Norges Bank acquired a new position in Option Care Health during the fourth quarter worth about $51,009,000. Point72 Asset Management L.P. boosted its holdings in Option Care Health by 262.7% during the fourth quarter. Point72 Asset Management L.P. now owns 1,686,143 shares of the company’s stock worth $50,736,000 after buying an additional 1,221,200 shares in the last quarter. Duquesne Family Office LLC boosted its holdings in Option Care Health by 389.0% during the fourth quarter. Duquesne Family Office LLC now owns 1,526,120 shares of the company’s stock worth $45,921,000 after buying an additional 1,214,020 shares in the last quarter. Vanguard Group Inc. boosted its holdings in Option Care Health by 8.1% during the third quarter. Vanguard Group Inc. now owns 15,269,619 shares of the company’s stock worth $480,534,000 after buying an additional 1,147,767 shares in the last quarter. Finally, Villere ST Denis J & Co. LLC boosted its holdings in Option Care Health by 620.5% during the first quarter. Villere ST Denis J & Co. LLC now owns 1,152,867 shares of the company’s stock worth $36,627,000 after buying an additional 992,868 shares in the last quarter. 94.75% of the stock is owned by institutional investors.
Analysts Set New Price Targets
Separately, Barrington Research lifted their price target on Option Care Health from $34.00 to $41.00 and gave the stock an “outperform” rating in a research note on Friday, July 28th.
Insider Buying and Selling at Option Care Health
In related news, insider Collin Smyser purchased 2,500 shares of the stock in a transaction on Monday, August 14th. The shares were bought at an average price of $34.69 per share, for a total transaction of $86,725.00. Following the completion of the acquisition, the insider now directly owns 2,500 shares in the company, valued at approximately $86,725. The purchase was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other news, insider Collin Smyser purchased 2,500 shares of the firm’s stock in a transaction on Monday, August 14th. The stock was bought at an average cost of $34.69 per share, for a total transaction of $86,725.00. Following the completion of the acquisition, the insider now directly owns 2,500 shares of the company’s stock, valued at $86,725. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director R Carter Pate purchased 1,465 shares of the firm’s stock in a transaction on Thursday, August 17th. The shares were purchased at an average price of $34.32 per share, with a total value of $50,278.80. Following the completion of the acquisition, the director now directly owns 106,112 shares of the company’s stock, valued at $3,641,763.84. The disclosure for this purchase can be found here. Insiders have purchased a total of 58,965 shares of company stock worth $2,041,654 over the last three months. Corporate insiders own 0.38% of the company’s stock.
Option Care Health Stock Down 0.7 %
Shares of Option Care Health stock opened at $34.57 on Friday. The stock has a 50-day moving average price of $33.40 and a 200 day moving average price of $31.44. The company has a market cap of $6.22 billion, a P/E ratio of 26.39, a P/E/G ratio of 1.21 and a beta of 1.20. The company has a current ratio of 1.79, a quick ratio of 1.40 and a debt-to-equity ratio of 0.72. Option Care Health, Inc. has a 1 year low of $24.23 and a 1 year high of $35.87.
Option Care Health (NASDAQ:OPCH – Get Free Report) last released its quarterly earnings data on Thursday, July 27th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.22 by $0.41. The firm had revenue of $1.07 billion for the quarter, compared to analyst estimates of $1.06 billion. Option Care Health had a net margin of 5.81% and a return on equity of 17.30%. As a group, analysts expect that Option Care Health, Inc. will post 1.42 EPS for the current fiscal year.
Option Care Health Company Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
- Five stocks we like better than Option Care Health
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- MarketBeat Week in Review – 8/28 – 9/1
- What is a SEC Filing?
- 2 Stocks That Doubled EPS Estimates and Flashing Buy Signals
- How to Invest in Lithium and Lithium Stocks
- Toyota vs Tesla: The Tortoise And The Hare Race Has A New Meaning
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.